Pharmaceuticals in Japan

"Datamonitor’s Pharmaceuticals in Japan industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of the industry’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of the industry

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by value and/or volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

* Market shares are covered by manufacturer or brand

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates.

For the purpose of this report Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

Table of Contents
TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Market Share 12
CHAPTER 6 Five Forces Analysis 13
6.1 Summary 13
6.2 Buyer Power 14
6.3 Supplier Power 15
6.4 New Entrants 17
6.5 Substitutes 18
6.6 Rivalry 19



CHAPTER 7 Leading Companies 20
7.1 Takeda Pharmaceutical Company Limited 20
7.2 Astellas Pharma 22
7.3 Pfizer Inc 24
7.4 Chugai Pharmaceutical Co. Ltd 27
CHAPTER 8 Market Forecasts 29
8.1 Market Value Forecast 29
CHAPTER 9 Macroeconomic Indicators 30
CHAPTER 10 Appendix 31
10.1 Methodology 31
10.2 Industry Associations 32
10.3 Related Datamonitor Research 32

LIST OF TABLES
Table 1: Japan Pharmaceuticals Market Value: $ million, 2003-2007 9
Table 2: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 10
Table 3: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 11
Table 4: Japan Pharmaceuticals Market Share: % Share, by Value, 2007 12
Table 5: Key Facts: Takeda Pharmaceutical Company Limited 20
Table 6: Key Financials: Takeda Pharmaceutical Company Limited 21
Table 7: Key Facts: Astellas Pharma 22
Table 8: Key Financials: Astellas Pharma 23
Table 9: Key Facts: Pfizer Inc 24
Table 10: Key Financials: Pfizer Inc 26
Table 11: Key Facts: Chugai Pharmaceutical Co. Ltd 27
Table 12: Key Financials: Chugai Pharmaceutical Co. Ltd 28
Table 13: Japan Pharmaceuticals Market Value Forecast: $ million, 2007-2012 29
Table 14: Japan Size of Population (million) , 2003-2007 30
Table 15: Japan GDP (Constant 2000 Prices, $ billion), 2003-2007 30
Table 16: Japan Exchange Rate, 2003 30

"